Take a trial of UK to unlock this pageFind out more

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 4th Jun, paid: 2nd Jul more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +5.8%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2014, Bioquell plc revenues increased 1% to L45.3M. Net loss totaled L1M vs. income of L3.1M. Revenues reflect TRaC segment increase of 7% to L18M, United Kingdom segment increase of 9% to L22M. Net loss reflects BIO segment loss totaling L2.9M vs. income of L1M, Unallocated Head Office Costs segment loss increase of 17% to L1.8M. Dividend per share remained flat at L0.03. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Dec '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2015
31st Dec 2016

Price Target: 1.49
(-2.91% below Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
2 brokers Broker Consensus Trend
Broker Recommendations for Bioquell
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 0 1 1

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , N+1 Singer Elizabeth Klein ,

Profile Summary

Bioquell PLC is a United Kingdom-based company. It is engaged in the designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries. It has two divisions: bio-decontamination (BIO) division is engaged in providing solutions based on hydrogen peroxide vapor technology to eradicate bacteria, viruses and fungi, throughout a range of applications. It also provides chemical, biological, radiological and nuclear defense filtration technology and specialist laboratory filtration equipment, and the TRaC division provides a range of services that include environmental testing, telecoms testing, radio testing, electromagnetic testing, safety testing.

Directors: Nicholas Adams (CEO) , Michael Roller (FID) 49, Georgina Pope (SEC) , Nigel Keen (NEC) , Tony Bourne (NID) 60, Ian Carruthers (NID) , Simon Constantine (NID) 55, Christopher Mills (NID) 62,

No. of Employees: 444 No. of Shareholders: n/a

Last Annual December 31st, 2014
Last Interim December 31st, 2014
Shares in Issue 42,535,363
Free Float 17.8m (41.9%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Fledgling , FTSE Fledgling Ex Investment Trusts ,
Exchange London Stock Exchange (Full)
Eligible for an ISA? a SIPP?

BQE Share Price Performance BQEQuote
-1.0  -0.7%
Traded 4:28pm · Minimum 15 min delayed · NMS: 1.50k

Latest BQE News Announcements (delayed)

Upcoming BQE Events
Thursday 4th June, 2015
Dividend For BQE.L
Tuesday 17th May, 2016 (estimate)
Bioquell PLC Annual Shareholders Meeting

Recent ↓
Monday 18th May, 2015
Bioquell PLC Annual Shareholders Meeting
Tuesday 5th May, 2015
Bioquell PLC Annual Shareholders Meeting
Wednesday 4th June, 2014
Dividend For BQE.L
Tuesday 18th March, 2014
Preliminary 2013 Bioquell PLC Earnings Release
Friday 17th January, 2014
Bioquell PLC Pre-Close Update on the year ended 31 December 2013
Friday 15th November, 2013
Bioquell PLC Interim Management Statement
Wednesday 28th August, 2013
Interim 2013 Bioquell PLC Earnings Release
Wednesday 5th June, 2013
Dividend For BQE.L
Monday 13th May, 2013
Bioquell PLC Annual General Meeting
Monday 13th May, 2013
Bioquell PLC Interim Management Statement for the period ended 12 May, 2013

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.

Should you buy BQE

Access BQE Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis